Systemic lupus erythematosus
Not recruitingEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial
Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial
- Disease:Systemic lupus erythematosus
- Substances:Litifilimab
Romania- Participants:18–64 years · 65+ years
- Substances:Litifilimab
